Propylthiouracil
Product Images NDC 0228-2348

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Propylthiouracil (NDC 0228-2348). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image 1

Image 1
Molecular formula C7H10N20S corresponds to a compound with a molecular weight of 170.23 g/mol. The text contains the structural formula of the molecule, which includes a chain of carbon and hydrogen atoms with a nitrogen atom attached to it, as well as a sulfur atom in the molecule. The text does not provide any contextual information or name of the molecule.*
FDA Label Image

Image 2

Image 2
FDA Label Image

Image 3

Image 3
This is a description of a medication called Propylthiouracil, which comes in tablet form. The NDC (National Drug Code) is 0228-2348-10 and the quantity is 100 tablets. Each tablet contains 50mg of Propylithiouracil USP. The recommended dosage should be found in the prescribing information accompanying the medication. The pharmacist should dispense the medication with the medication guide. It should be stored in a well-closed container at 25°C (77°F) but can have excursions permitted to 15° to 30°C (59° to 86°F). The manufacturer is Teva Pharmaceuticals located in Parsippany, NJ 07054. The LOT/EXP (lot number and expiration date) is also provided as 0228-2348-10.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.